Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease
An association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) has been suggested. The purpose of this study was to compare the disease course of patients with both MS and IBD with that of patients with isolated MS or isolated IBD. Sixty-six MS-IBD patients were identified and w...
Gespeichert in:
| Veröffentlicht in: | Multiple sclerosis 2014-07, Vol.20 (8), p.1135-1139 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1139 |
|---|---|
| container_issue | 8 |
| container_start_page | 1135 |
| container_title | Multiple sclerosis |
| container_volume | 20 |
| creator | Zéphir, Hélène Gower-Rousseau, Corinne Salleron, Julia Simon, Olivier Debouverie, Marc Le Page, Emmanuelle Bouhnik, Yoram Lebrun-Frenay, Christine Papeix, Caroline Vigneron, Benoît Allez, Matthieu Prin, Lionel Cosnes, Jacques Vermersch, Patrick Colombel, Jean-Frédéric |
| description | An association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) has been suggested. The purpose of this study was to compare the disease course of patients with both MS and IBD with that of patients with isolated MS or isolated IBD. Sixty-six MS-IBD patients were identified and were matched with 251 isolated MS and 257 isolated IBD controls. Main outcomes were scores using the Expanded Disability Status Scale (EDSS) in MS and extent of disease extension in IBD at last clinical evaluation. After a median 12 years of disease duration, the median EDSS and the percentages of patients reaching an EDSS of 3.0 and 4.0 were significantly lower in MS-IBD patients than in controls. MS had no impact on IBD. MS course appears to be milder in patients with concomitant IBD. |
| doi_str_mv | 10.1177/1352458513515081 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00917585v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1352458513515081</sage_id><sourcerecordid>1800701156</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-65ffb4a13349064b29e188765abbf520575da501270354f11718cd3ff66cd3d13</originalsourceid><addsrcrecordid>eNqFkc9rFTEQx4Mo9ofePcmCCHrYmsnvPZairfCkFwVvIZtNbEp295lkW_rfN8t71lIQTzPMfObXdxB6A_gEQMpPQDlhXPFqgWMFz9AhMClb3En8vPo13a75A3SU8zXGWErKX6IDwigRQpJD9PNbiINLzbjEErbRNdlGl-YccmPnJWXXhKnZmhLcVHJzG8pVjU92HkMxU6lJH804mjKnu6afb11shpCdye4VeuFNzO713h6jH18-fz-7aDeX51_PTjetZYKUVnDve2aAUtZhwXrSOVBKCm763nOCueSD4RiIxJQzX68GZQfqvRDVDECP0cdd3ysT9TaF0aQ7PZugL043eo1h3IGsGtys7Icdu03z78XloseQrYvRTG5esgZVFcIAXPwfFYpWdbHsKvruCXpdlZvq0Ro4k6ojrFtn4x1lq7o5Of-wLGC9PlM_fWYtebtvvPSjGx4K_nyvAu_3gMnWRJ_MZEP-yykuVW1duXbHZfPLPdruX4PvASxKsQs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547892491</pqid></control><display><type>article</type><title>Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease</title><source>MEDLINE</source><source>Sage Journals</source><creator>Zéphir, Hélène ; Gower-Rousseau, Corinne ; Salleron, Julia ; Simon, Olivier ; Debouverie, Marc ; Le Page, Emmanuelle ; Bouhnik, Yoram ; Lebrun-Frenay, Christine ; Papeix, Caroline ; Vigneron, Benoît ; Allez, Matthieu ; Prin, Lionel ; Cosnes, Jacques ; Vermersch, Patrick ; Colombel, Jean-Frédéric</creator><creatorcontrib>Zéphir, Hélène ; Gower-Rousseau, Corinne ; Salleron, Julia ; Simon, Olivier ; Debouverie, Marc ; Le Page, Emmanuelle ; Bouhnik, Yoram ; Lebrun-Frenay, Christine ; Papeix, Caroline ; Vigneron, Benoît ; Allez, Matthieu ; Prin, Lionel ; Cosnes, Jacques ; Vermersch, Patrick ; Colombel, Jean-Frédéric ; CFSEP, GETAID and EPIMAD Groups ; for the CFSEP, GETAID and EPIMAD Groups</creatorcontrib><description>An association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) has been suggested. The purpose of this study was to compare the disease course of patients with both MS and IBD with that of patients with isolated MS or isolated IBD. Sixty-six MS-IBD patients were identified and were matched with 251 isolated MS and 257 isolated IBD controls. Main outcomes were scores using the Expanded Disability Status Scale (EDSS) in MS and extent of disease extension in IBD at last clinical evaluation. After a median 12 years of disease duration, the median EDSS and the percentages of patients reaching an EDSS of 3.0 and 4.0 were significantly lower in MS-IBD patients than in controls. MS had no impact on IBD. MS course appears to be milder in patients with concomitant IBD.</description><identifier>ISSN: 1352-4585</identifier><identifier>EISSN: 1477-0970</identifier><identifier>DOI: 10.1177/1352458513515081</identifier><identifier>PMID: 24326672</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Biological and medical sciences ; Case-Control Studies ; Chemical Sciences ; Colitis, Ulcerative - diagnosis ; Colitis, Ulcerative - epidemiology ; Colitis, Ulcerative - immunology ; Crohn Disease - diagnosis ; Crohn Disease - epidemiology ; Crohn Disease - immunology ; Cross-Sectional Studies ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Disability Evaluation ; Female ; France - epidemiology ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Immunomodulators ; Male ; Medical sciences ; Multiple Sclerosis - diagnosis ; Multiple Sclerosis - epidemiology ; Multiple Sclerosis - immunology ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Neurology ; Organic chemistry ; Other diseases. Semiology ; Pharmacology. Drug treatments ; Prognosis ; Protective Factors ; Risk Factors ; Severity of Illness Index ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Time Factors</subject><ispartof>Multiple sclerosis, 2014-07, Vol.20 (8), p.1135-1139</ispartof><rights>The Author(s) 2013</rights><rights>2015 INIST-CNRS</rights><rights>The Author(s) 2013.</rights><rights>SAGE Publications © Jul 2014</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-65ffb4a13349064b29e188765abbf520575da501270354f11718cd3ff66cd3d13</citedby><cites>FETCH-LOGICAL-c462t-65ffb4a13349064b29e188765abbf520575da501270354f11718cd3ff66cd3d13</cites><orcidid>0000-0003-4029-2012 ; 0000-0003-4074-6125 ; 0000-0002-7921-4583 ; 0000-0002-5787-4943 ; 0000-0003-0997-8817 ; 0000-0002-6659-6148 ; 0000-0002-2012-7522 ; 0000-0002-3713-2416</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1352458513515081$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1352458513515081$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>230,314,780,784,885,21818,27923,27924,43620,43621</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28578117$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24326672$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00917585$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Zéphir, Hélène</creatorcontrib><creatorcontrib>Gower-Rousseau, Corinne</creatorcontrib><creatorcontrib>Salleron, Julia</creatorcontrib><creatorcontrib>Simon, Olivier</creatorcontrib><creatorcontrib>Debouverie, Marc</creatorcontrib><creatorcontrib>Le Page, Emmanuelle</creatorcontrib><creatorcontrib>Bouhnik, Yoram</creatorcontrib><creatorcontrib>Lebrun-Frenay, Christine</creatorcontrib><creatorcontrib>Papeix, Caroline</creatorcontrib><creatorcontrib>Vigneron, Benoît</creatorcontrib><creatorcontrib>Allez, Matthieu</creatorcontrib><creatorcontrib>Prin, Lionel</creatorcontrib><creatorcontrib>Cosnes, Jacques</creatorcontrib><creatorcontrib>Vermersch, Patrick</creatorcontrib><creatorcontrib>Colombel, Jean-Frédéric</creatorcontrib><creatorcontrib>CFSEP, GETAID and EPIMAD Groups</creatorcontrib><creatorcontrib>for the CFSEP, GETAID and EPIMAD Groups</creatorcontrib><title>Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease</title><title>Multiple sclerosis</title><addtitle>Mult Scler</addtitle><description>An association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) has been suggested. The purpose of this study was to compare the disease course of patients with both MS and IBD with that of patients with isolated MS or isolated IBD. Sixty-six MS-IBD patients were identified and were matched with 251 isolated MS and 257 isolated IBD controls. Main outcomes were scores using the Expanded Disability Status Scale (EDSS) in MS and extent of disease extension in IBD at last clinical evaluation. After a median 12 years of disease duration, the median EDSS and the percentages of patients reaching an EDSS of 3.0 and 4.0 were significantly lower in MS-IBD patients than in controls. MS had no impact on IBD. MS course appears to be milder in patients with concomitant IBD.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Chemical Sciences</subject><subject>Colitis, Ulcerative - diagnosis</subject><subject>Colitis, Ulcerative - epidemiology</subject><subject>Colitis, Ulcerative - immunology</subject><subject>Crohn Disease - diagnosis</subject><subject>Crohn Disease - epidemiology</subject><subject>Crohn Disease - immunology</subject><subject>Cross-Sectional Studies</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Disability Evaluation</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multiple Sclerosis - diagnosis</subject><subject>Multiple Sclerosis - epidemiology</subject><subject>Multiple Sclerosis - immunology</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>Neurology</subject><subject>Organic chemistry</subject><subject>Other diseases. Semiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prognosis</subject><subject>Protective Factors</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Time Factors</subject><issn>1352-4585</issn><issn>1477-0970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkc9rFTEQx4Mo9ofePcmCCHrYmsnvPZairfCkFwVvIZtNbEp295lkW_rfN8t71lIQTzPMfObXdxB6A_gEQMpPQDlhXPFqgWMFz9AhMClb3En8vPo13a75A3SU8zXGWErKX6IDwigRQpJD9PNbiINLzbjEErbRNdlGl-YccmPnJWXXhKnZmhLcVHJzG8pVjU92HkMxU6lJH804mjKnu6afb11shpCdye4VeuFNzO713h6jH18-fz-7aDeX51_PTjetZYKUVnDve2aAUtZhwXrSOVBKCm763nOCueSD4RiIxJQzX68GZQfqvRDVDECP0cdd3ysT9TaF0aQ7PZugL043eo1h3IGsGtys7Icdu03z78XloseQrYvRTG5esgZVFcIAXPwfFYpWdbHsKvruCXpdlZvq0Ro4k6ojrFtn4x1lq7o5Of-wLGC9PlM_fWYtebtvvPSjGx4K_nyvAu_3gMnWRJ_MZEP-yykuVW1duXbHZfPLPdruX4PvASxKsQs</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Zéphir, Hélène</creator><creator>Gower-Rousseau, Corinne</creator><creator>Salleron, Julia</creator><creator>Simon, Olivier</creator><creator>Debouverie, Marc</creator><creator>Le Page, Emmanuelle</creator><creator>Bouhnik, Yoram</creator><creator>Lebrun-Frenay, Christine</creator><creator>Papeix, Caroline</creator><creator>Vigneron, Benoît</creator><creator>Allez, Matthieu</creator><creator>Prin, Lionel</creator><creator>Cosnes, Jacques</creator><creator>Vermersch, Patrick</creator><creator>Colombel, Jean-Frédéric</creator><general>SAGE Publications</general><general>Sage Publications</general><general>Sage Publications Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-4029-2012</orcidid><orcidid>https://orcid.org/0000-0003-4074-6125</orcidid><orcidid>https://orcid.org/0000-0002-7921-4583</orcidid><orcidid>https://orcid.org/0000-0002-5787-4943</orcidid><orcidid>https://orcid.org/0000-0003-0997-8817</orcidid><orcidid>https://orcid.org/0000-0002-6659-6148</orcidid><orcidid>https://orcid.org/0000-0002-2012-7522</orcidid><orcidid>https://orcid.org/0000-0002-3713-2416</orcidid></search><sort><creationdate>20140701</creationdate><title>Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease</title><author>Zéphir, Hélène ; Gower-Rousseau, Corinne ; Salleron, Julia ; Simon, Olivier ; Debouverie, Marc ; Le Page, Emmanuelle ; Bouhnik, Yoram ; Lebrun-Frenay, Christine ; Papeix, Caroline ; Vigneron, Benoît ; Allez, Matthieu ; Prin, Lionel ; Cosnes, Jacques ; Vermersch, Patrick ; Colombel, Jean-Frédéric</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-65ffb4a13349064b29e188765abbf520575da501270354f11718cd3ff66cd3d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Chemical Sciences</topic><topic>Colitis, Ulcerative - diagnosis</topic><topic>Colitis, Ulcerative - epidemiology</topic><topic>Colitis, Ulcerative - immunology</topic><topic>Crohn Disease - diagnosis</topic><topic>Crohn Disease - epidemiology</topic><topic>Crohn Disease - immunology</topic><topic>Cross-Sectional Studies</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Disability Evaluation</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multiple Sclerosis - diagnosis</topic><topic>Multiple Sclerosis - epidemiology</topic><topic>Multiple Sclerosis - immunology</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>Neurology</topic><topic>Organic chemistry</topic><topic>Other diseases. Semiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prognosis</topic><topic>Protective Factors</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zéphir, Hélène</creatorcontrib><creatorcontrib>Gower-Rousseau, Corinne</creatorcontrib><creatorcontrib>Salleron, Julia</creatorcontrib><creatorcontrib>Simon, Olivier</creatorcontrib><creatorcontrib>Debouverie, Marc</creatorcontrib><creatorcontrib>Le Page, Emmanuelle</creatorcontrib><creatorcontrib>Bouhnik, Yoram</creatorcontrib><creatorcontrib>Lebrun-Frenay, Christine</creatorcontrib><creatorcontrib>Papeix, Caroline</creatorcontrib><creatorcontrib>Vigneron, Benoît</creatorcontrib><creatorcontrib>Allez, Matthieu</creatorcontrib><creatorcontrib>Prin, Lionel</creatorcontrib><creatorcontrib>Cosnes, Jacques</creatorcontrib><creatorcontrib>Vermersch, Patrick</creatorcontrib><creatorcontrib>Colombel, Jean-Frédéric</creatorcontrib><creatorcontrib>CFSEP, GETAID and EPIMAD Groups</creatorcontrib><creatorcontrib>for the CFSEP, GETAID and EPIMAD Groups</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Family Health Database (ProQuest)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Multiple sclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zéphir, Hélène</au><au>Gower-Rousseau, Corinne</au><au>Salleron, Julia</au><au>Simon, Olivier</au><au>Debouverie, Marc</au><au>Le Page, Emmanuelle</au><au>Bouhnik, Yoram</au><au>Lebrun-Frenay, Christine</au><au>Papeix, Caroline</au><au>Vigneron, Benoît</au><au>Allez, Matthieu</au><au>Prin, Lionel</au><au>Cosnes, Jacques</au><au>Vermersch, Patrick</au><au>Colombel, Jean-Frédéric</au><aucorp>CFSEP, GETAID and EPIMAD Groups</aucorp><aucorp>for the CFSEP, GETAID and EPIMAD Groups</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease</atitle><jtitle>Multiple sclerosis</jtitle><addtitle>Mult Scler</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>20</volume><issue>8</issue><spage>1135</spage><epage>1139</epage><pages>1135-1139</pages><issn>1352-4585</issn><eissn>1477-0970</eissn><abstract>An association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) has been suggested. The purpose of this study was to compare the disease course of patients with both MS and IBD with that of patients with isolated MS or isolated IBD. Sixty-six MS-IBD patients were identified and were matched with 251 isolated MS and 257 isolated IBD controls. Main outcomes were scores using the Expanded Disability Status Scale (EDSS) in MS and extent of disease extension in IBD at last clinical evaluation. After a median 12 years of disease duration, the median EDSS and the percentages of patients reaching an EDSS of 3.0 and 4.0 were significantly lower in MS-IBD patients than in controls. MS had no impact on IBD. MS course appears to be milder in patients with concomitant IBD.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>24326672</pmid><doi>10.1177/1352458513515081</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-4029-2012</orcidid><orcidid>https://orcid.org/0000-0003-4074-6125</orcidid><orcidid>https://orcid.org/0000-0002-7921-4583</orcidid><orcidid>https://orcid.org/0000-0002-5787-4943</orcidid><orcidid>https://orcid.org/0000-0003-0997-8817</orcidid><orcidid>https://orcid.org/0000-0002-6659-6148</orcidid><orcidid>https://orcid.org/0000-0002-2012-7522</orcidid><orcidid>https://orcid.org/0000-0002-3713-2416</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1352-4585 |
| ispartof | Multiple sclerosis, 2014-07, Vol.20 (8), p.1135-1139 |
| issn | 1352-4585 1477-0970 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_00917585v1 |
| source | MEDLINE; Sage Journals |
| subjects | Adult Biological and medical sciences Case-Control Studies Chemical Sciences Colitis, Ulcerative - diagnosis Colitis, Ulcerative - epidemiology Colitis, Ulcerative - immunology Crohn Disease - diagnosis Crohn Disease - epidemiology Crohn Disease - immunology Cross-Sectional Studies Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Disability Evaluation Female France - epidemiology Gastroenterology. Liver. Pancreas. Abdomen Humans Immunomodulators Male Medical sciences Multiple Sclerosis - diagnosis Multiple Sclerosis - epidemiology Multiple Sclerosis - immunology Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology Organic chemistry Other diseases. Semiology Pharmacology. Drug treatments Prognosis Protective Factors Risk Factors Severity of Illness Index Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Time Factors |
| title | Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A03%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Milder%20multiple%20sclerosis%20course%20in%20patients%20with%20concomitant%20inflammatory%20bowel%20disease&rft.jtitle=Multiple%20sclerosis&rft.au=Z%C3%A9phir,%20H%C3%A9l%C3%A8ne&rft.aucorp=CFSEP,%20GETAID%20and%20EPIMAD%20Groups&rft.date=2014-07-01&rft.volume=20&rft.issue=8&rft.spage=1135&rft.epage=1139&rft.pages=1135-1139&rft.issn=1352-4585&rft.eissn=1477-0970&rft_id=info:doi/10.1177/1352458513515081&rft_dat=%3Cproquest_hal_p%3E1800701156%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1547892491&rft_id=info:pmid/24326672&rft_sage_id=10.1177_1352458513515081&rfr_iscdi=true |